Inspira Technologies Oxy B.H.N. Ltd. (IINNW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
Ha-Tidhar St 2
Raanana, 4366504
Israel
Phone
972 4 623 0333
Sector
Healthcare
Industry
Medical - Devices
Employees
37
First IPO Date
July 14, 2021
| Name | Title | Pay | Year Born |
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer & Director | 359,037 | 1976 |
| Daniella Yeheskely-Hayon | Chief Technology Officer | 261,624 | 1977 |
| Yafit Tehila | Chief Financial Officer | 269,693 | 1981 |
| Avi Shabtai | Chief Operating Officer and Vice President of Research & Development | 344,302 | 1974 |
| Mike Hershkovitz | Vice President of Global Sales | 0 | N/A |
| Adi Shmueli | Director of Marketing | 0 | N/A |
| Yoav Rozanovich | Chief Business Officer | 0 | N/A |
| Sivan Ozeri | Administrative Manager | 0 | N/A |
Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company dedicated to developing, manufacturing, and marketing innovative respiratory support technologies. Their core mission is to offer a non-invasive treatment alternative to traditional mechanical ventilation for individuals experiencing respiratory failure. The company's flagship product is the Augmented Respiration Technology (ART) system. This respiratory assistance device features a portable, minimally invasive dual-lumen cannula, which is inserted into the jugular vein. The ART system works by directly oxygenating blood outside the body (extracorporeal oxygenation), effectively elevating and stabilizing declining oxygen saturation levels. Originally incorporated in 2018 as Insense Medical Ltd., the company changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020 and is based in Ra'annana, Israel.